ArticleInternational journal of hematology2017

Marked response to imatinib mesylate in a patient with platelet-derived growth factor receptor beta-associated acute myeloid leukemia.

Yoshimitsu Shimomura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.